A survey of palivizumab for infants with cystic fibrosis in the UK

Of these, 70 infants were diagnosed by newborn screening (48.6%); 16 (11.2%) of the 143 infants were hospitalised owing to RSV infection; none required paediatric intensive care unit admission and none died; 14 (9.8%) infants received palivizumab between three cystic fibrosis centres, and one of the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Archives of disease in childhood 2007-01, Vol.92 (1), p.87-88
Hauptverfasser: McCormick, J, Southern, K W
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Of these, 70 infants were diagnosed by newborn screening (48.6%); 16 (11.2%) of the 143 infants were hospitalised owing to RSV infection; none required paediatric intensive care unit admission and none died; 14 (9.8%) infants received palivizumab between three cystic fibrosis centres, and one of these infants was subsequently hospitalised with RSV infection (other risk factors for this infant were not reported).
ISSN:0003-9888
1468-2044
DOI:10.1136/adc.2006.0105338